Video

Expert Discusses Formulary Changes in Oncology Biosimilars at AMCP Annual Meeting

In an interview with Pharmacy Times®, Eric Tichy, PharmD, MBA, BCPS, FAST, FCCP, Vice Chair of Pharmacy/Formulary at Mayo Clinic, discusses some formulary trends in biosimilars at the Academy of Managed Care Pharmacy Annual Meeting.

In an interview with Pharmacy Times®, Eric Tichy, PharmD, MBA, BCPS, FAST, FCCP, Vice Chair of Pharmacy/Formulary at Mayo Clinic, discussed some formulary trends in the oncology biosimilars space at the Academy of Managed Care Pharmacy Annual Meeting.

Q: What are some formulary trends in the oncology biosimilars space this year?

Eric Tichy: Well, the oncology biosimilar space is really taking off. We've seen that the biosimilars are now more than half of the purchases of those therapeutic agents. So that's kind of a big inflection point where we hadn't seen that with other biosimilars.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com